Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Clin Exp Pharmacol Physiol. 2011 May;38(5):328–333. doi: 10.1111/j.1440-1681.2011.05509.x

Figure 2.

Figure 2

eNOS immunprecipitation of HUVECs treated with 20-HETE (10μM), under basal and VEGF stimulated conditions (n=3). Fold change where black bars are p-eNOS/eNOS and white bars are Hsp90/eNOS. ANOVA with Dunnett's post-hoc analysis *p<0.05 versus control.